FDA NDC Directory · JSON-LD · Markdown

SymlinPen

NDC 0310-6615 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namepramlintide acetate
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryNew Drug Application (innovator) · App NDA021332
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsPRAMLINTIDE ACETATE (1000 ug/mL)
Marketing started20150108
Marketing ended20270131
Package count1

External sources

Source: openFDA. Public-domain (CC0).